CLINICAL_TRIALS
trial_result
· 2017-11-29
Clinical Trial Update: GSK2251052 in the Treatment of Complicated Intra-abdominal Infections [Phase 2]
Summary
A Phase 2 trial of GSK2251052 for complicated intra-abdominal infections was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Infections, Intestinal | Phase 2 | Status: TERMINATED | Results posted: 2017-11-29